Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy

International Journal of Urology

Volumn 9, Issue 8, 2002, Pages 427-430

  Tsuru, Nobuo ^a   Kurita, Yutaka ^a   Masuda, Hiroaki ^a   Suzuki, Kazuo ^a   Fujita, Kimio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Benign prostatic hyperplasia; Power Doppler imaging; Resistive index; Transition zone; Transrectal ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; URETHRA; URETHRA OBSTRUCTION; UROFLOWMETRY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER; URETHRA; VASCULAR RESISTANCE;

EID: 0036378374     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00494.x     Document Type: Article

References (17)

1. McConnell JD, Barry MJ, Bruskewitz RC et al. Benign prostatic hyperplasia: Diagnosis and Treatment. Clinical Practice Guidelines, Number 8. AHCPR Publication No. 94-0582. Agency for Health Care Policy and Research, Public Health Service. Rockville: Department of Health and Human Services (US); 1994.
2. Kojima M, Naya Y, Inoue W et al. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age. Volume and ultrasonic appearance of the prostate. J. Urol. 1997; 157: 2160-6.
3. Kojima M, Ochiai A, Naya Y, Ukimura O, Watanabe M, Watanabe H. Correlation of presumed circle area ratio with intravesical obstruction in men with lower urinary tract symptoms. Urology 1997; 50: 548-55.
4. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998; 51: 595-600.
5. McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol. Clin. North Am. 1990; 17: 477-86.
6. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186: 509-13.
7. Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: Examination with color Doppler US. Radiology 1995; 196: 453-7.
8. Rifkin MD. Ultrasound of the Prostate - Imaging in the Diagnosis and Therapy of Prostatic Disease, 2nd edn. Philadelphia, Lippincott-Raven, 1997.
9. Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O. Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med. Biol. 1997; 23: 1305-9.
10. Hendrikx A, Klomp M, Keyzer J, Arends B, Zonneveld G. The role of velocity imaging (CVI) in prostate ultrasound. Eur. J. Ultrasound 1996; 3: 15-23.
11. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler: A potentially useful alternative to mean-frequency based color Doppler sonography. Radiology 1994; 190: 853-6.
12. Nelson TR, Pretorius DH. The Doppler signal: Where does it come from and what does it mean? Am. J. Radiol. 1988; 151: 439-47.
13. Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. 1992; 148: 1549-77.
14. Ohe H. Benign prostatic hypertrophy. In: Watanabe H, Holms JH, Holm HH, Goldberg BB (eds). Diagnostic Ultrasound in Urology and Nephrology. Igaku-Shoin, Tokyo, 1981; 123-9.
15. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: Correlation with symptoms, urine flow and detrusor pressure. J. Urol. 1995; 154: 1764-9.
16. Saloner R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in Eastern Finland. Arteriosclerosis 1988; 8: 788-92.
17. Handa N, Matsumoto M, Maeda H et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 2: 1567-72.